Riskpilot← Back to searchSign inGet full accessAPOKUS AS
ASActiveOrg 984902638Slemdalsveien 1, 0369 OsloComputer programming activities · NACE 6210Est. 200211 employees
Revenue 2024
NOK 18,7M
+14% vs 2023
EBITDA margin
0.1%
-96% vs 2023
Equity ratio
73.9%
Financial strength
Net profit 2024
NOK 329K
-58% vs 2023
| Revenue | NOK 18,7M | +14% |
| EBITDA | NOK 28K | -96% |
| Net profit | NOK 329K | -58% |
| Total assets | NOK 9,3M | +6% |
| Equity | NOK 6,9M | +5% |
| Employees | 11 | — |
Legal name
APOKUS AS
Org number
984902638
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
5. oktober 2002
Share capital
NOK 500 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Gjennom praksisnære prosjekter og opplæringsvirksomhet videreutvikle helsepersonell i apotek som legemiddelrådgivere og apotek som faghandel for legemidler. Selskapet skal bidra til å fremme samhandling mellom apotek og resten av helse-norge til beste for legemiddelbrukeren.
Address
Slemdalsveien 1, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 929 | 447 | 159 | 75 | 5 566 | 8 125 | 9 560 | 11 028 | 12 754 | 11 320 | 12 404 | 12 854 | 14 241 | 12 127 | 15 695 | 16 406 | 18 691 |
| Staff expenses | −1 209 | −186 | 196 | −714 | −3 797 | −5 248 | −6 175 | −7 650 | −9 599 | −14 342 | −9 376 | −9 510 | −9 816 | −8 384 | −10 251 | −11 400 | −12 036 |
| EBITDA | −30 | −6 | −3 | −1 410 | −1 249 | 439 | 1 020 | 822 | 147 | −5 828 | −151 | 379 | 1 341 | 593 | 474 | 712 | 28 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −28 | −52 | −71 | −105 | −113 | −149 | −144 | −260 | −222 | −205 | −137 | −105 | −45 |
| EBIT | −30 | −6 | −3 | −1 410 | −1 277 | 388 | 949 | 717 | 34 | −5 976 | −294 | 118 | 1 120 | 388 | 337 | 607 | −17 |
| Net financials | 30 | 6 | 3 | 27 | 39 | 32 | 37 | 30 | 28 | 19 | 26 | 36 | 16 | 9 | 60 | 180 | 346 |
| Profit before tax | 0 | 0 | 0 | −1 383 | −1 238 | 419 | 986 | 747 | 62 | −5 958 | −268 | 155 | 1 135 | 397 | 397 | 787 | 329 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | −1 383 | −1 238 | 419 | 986 | 747 | 62 | −5 958 | −268 | 155 | 1 135 | 397 | 397 | 787 | 329 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 278 | 944 | 397 | 2 250 | 2 586 | 3 262 | 4 348 | 5 263 | 5 383 | 5 050 | 5 472 | 5 476 | 6 740 | 7 032 | 7 841 | 8 796 | 9 281 |
| Equity | 294 | 294 | 294 | 1 611 | 1 373 | 1 792 | 2 778 | 3 525 | 3 587 | −2 370 | 3 661 | 3 816 | 4 952 | 5 349 | 5 745 | 6 532 | 6 861 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 984 | 650 | 103 | 639 | 1 213 | 1 470 | 1 570 | 1 739 | 1 796 | 7 421 | 1 810 | 1 660 | 1 788 | 1 684 | 2 095 | 2 264 | 2 420 |
| Total debt | 984 | 650 | 103 | 639 | 1 213 | 1 470 | 1 570 | 1 739 | 1 796 | 7 421 | 1 810 | 1 660 | 1 788 | 1 684 | 2 095 | 2 264 | 2 420 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20082024
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
20082024
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20082024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20082024
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20082024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ER Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
IJ Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Stiftelsen Til Fremme Av Norsk Apotekfarmasi | Company | 66.0% | 66.0% | 2024 |
Apotekforeningen | Company | 34.0% | 34.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apotekforeningen
APOKUS AS Board members of APOKUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Rugnes Andersen | Chief Executive Officer | 0 companies |
| Inger Johanne Østegaard Kjelsen | Chief Executive Officer | 0 companies |
| Hans Petter Heide Johannessen | Chairman | 0 companies |
| Leif Ola Rød | Board of Directors | 0 companies |
| Karianne Kjos Ødegård | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |
| Lotte Fonnesbæk | Board of Directors | 0 companies |
| Anne Berit Walter | Board of Directors | 0 companies |